Literature DB >> 2407871

Projections of AIDS morbidity and mortality in San Francisco.

G F Lemp1, S F Payne, G W Rutherford, N A Hessol, W Winkelstein, J A Wiley, A R Moss, R E Chaisson, R T Chen, D W Feigal.   

Abstract

To develop a model for predicting acquired immunodeficiency syndrome (AIDS) morbidity in San Francisco, Calif, through June 1993, we combined annual human immunodeficiency virus seroconversion rates for homosexual and bisexual men and for heterosexual intravenous drug users with estimates of the cumulative proportion of the population with AIDS by duration of human immunodeficiency virus infection and with estimates of the size of the at-risk populations. We projected AIDS mortality by applying Kaplan-Meier estimates of survival time following diagnosis to the projected number of cases. The median incubation period for AIDS among homosexual and bisexual men infected with the human immunodeficiency virus was estimated to be 11.0 years (mean, 11.8 years; 95% confidence interval, 10.6 to 13.0 years). The model projects 12,349 to 17,022 cumulative cases of AIDS in San Francisco through June 1993, with 9,966 to 12,767 cumulative deaths.

Entities:  

Mesh:

Year:  1990        PMID: 2407871

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  24 in total

1.  Women and HIV infection and AIDS in Canada: should we worry?

Authors:  C A Hankins
Journal:  CMAJ       Date:  1990-12-01       Impact factor: 8.262

2.  Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction.

Authors:  S Menzo; P Bagnarelli; M Giacca; A Manzin; P E Varaldo; M Clementi
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

Review 3.  Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection.

Authors:  M Clementi; S Menzo; P Bagnarelli; A Valenza; S Paolucci; R Sampaolesi; A Manzin; P E Varaldo
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

4.  HIV infection among Quebec women giving birth to live infants.

Authors:  C A Hankins; C Laberge; N Lapointe; M T Lai Tung; L Racine; M O'Shaughnessy
Journal:  CMAJ       Date:  1990-11-01       Impact factor: 8.262

5.  Decline in human immunodeficiency virus seropositivity and seroconversion in US Navy enlisted personnel: 1986 to 1989. Navy HIV Working Group.

Authors:  F C Garland; E D Gorham; S O Cunnion; M R Miller; L L Balazs
Journal:  Am J Public Health       Date:  1992-04       Impact factor: 9.308

6.  Prospective study of antigenemia, plasma viremia and lymphocytic viremia in HIV-infected hemophiliacs.

Authors:  S Melón Garcia; M de Oña Navarro; C Rodriguez Pinto; M Fernández Urgellés; A Martinez Gutierrez; P de la Iglesia; F J Mendez García
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-05       Impact factor: 3.267

7.  A method for identifying persons at high risk for sexually transmitted infections: opportunity for targeting intervention.

Authors:  C A Richert; T A Peterman; A A Zaidi; R L Ransom; J E Wroten; J J Witte
Journal:  Am J Public Health       Date:  1993-04       Impact factor: 9.308

Review 8.  The estimated prevalence and incidence of HIV in 96 large US metropolitan areas.

Authors:  S D Holmberg
Journal:  Am J Public Health       Date:  1996-05       Impact factor: 9.308

9.  Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism.

Authors:  B Chesebro; K Wehrly; J Nishio; S Perryman
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

Review 10.  Zalcitabine. A review of its pharmacology and clinical potential in acquired immunodeficiency syndrome (AIDS).

Authors:  R Whittington; R N Brogden
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.